Press release: Neurizon's NUZ-001 Reduces Aggregation of Key ALS Disease Target TDP-43 in Preclinical Study
Ncardia Launches Panel of Ready-to-Use Assays to Streamline Screening and Selection of New Therapeutic Candidates
Press release: Ncardia And Cellistic Recruit Charles Jacques as new Chief Financial Officer
Press release: Ncardia and Cellistic recruit Gustavo Mahler to lead the businesses through their next phase of growth
Press release: Ncardia launches Cellistic, an iPSC cell therapy CDMO
Press release: Ncardia Appoints Andy Holt as Chief Commercial Officer
Subscribe to our newsletter
Stay up to date on iPSC innovations, events and news.
